MDIT OTC
Medite Cancer Diagnostics, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$7M
-26.3% ▼
Gross Profit
-$131K
-103.8% ▼
Operating Income
-$6M
-290.1% ▼
Net Income
-$7M
-214.9% ▼
EPS (Diluted)
$-0.26
-160.0% ▼
EBITDA
-$6M
-327.6% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2015 | FY2016 | FY2017 |
|---|---|---|---|
| Revenue | $10M | $9M | $7M |
| YoY Growth | +0.0% | -6.6% | -26.3% |
| Cost of Revenue | $6M | $6M | $7M |
| Gross Profit | $4M | $3M | -$131K |
| Gross Margin | 36.7% | 37.0% | -1.9% |
| R&D Expenses | $1M | $1M | $1M |
| SG&A Expenses | $3M | $4M | $5M |
| Operating Expenses | $4M | $5M | $6M |
| Operating Income | -$599K | -$2M | -$6M |
| Operating Margin | -6.1% | -18.0% | -95.1% |
| Interest Expense | $204K | $694K | $849K |
| Income Before Tax | -$781K | -$2M | -$7M |
| Tax Expense | $78K | -$132K | -$487K |
| Net Income | -$859K | -$2M | -$7M |
| Net Margin | -8.7% | -23.4% | -100.0% |
| EPS (Diluted) | $-0.04 | $-0.10 | $-0.26 |
| EBITDA | -$422K | -$1M | -$6M |
| Shares Outstanding | 20M | 21M | 26M |